Westover Capital Advisors’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-5,012
| Closed | -$396K | – | 190 |
|
|
2023
Q4 | $396K | Sell |
5,012
-2,186
| -30% | -$156K | 0.13% | 116 |
|
|
2023
Q3 | $503K | Sell |
7,198
-4,242
| -37% | -$301K | 0.18% | 100 |
|
|
2023
Q2 | $791K | Sell |
11,440
-30,601
| -73% | -$2.18M | 0.27% | 84 |
|
|
2023
Q1 | $3.12M | Buy |
42,041
+1,032
| +3% | +$86.5K | 1.16% | 25 |
|
|
2022
Q4 | $3.82M | Sell |
41,009
-1,370
| -3% | -$132K | 1.51% | 21 |
|
|
2022
Q3 | $4.04M | Buy |
42,379
+1,702
| +4% | +$168K | 1.55% | 16 |
|
|
2022
Q2 | $3.77M | Sell |
40,677
-952
| -2% | -$92.9K | 1.39% | 23 |
|
|
2022
Q1 | $4.21M | Sell |
41,629
-2,113
| -5% | -$222K | 1.31% | 23 |
|
|
2021
Q4 | $4.51M | Sell |
43,742
-2,628
| -6% | -$243K | 1.31% | 23 |
|
|
2021
Q3 | $3.94M | Buy |
46,370
+175
| +0.4% | +$14.7K | 1.23% | 26 |
|
|
2021
Q2 | $3.85M | Sell |
46,195
-672
| -1% | -$55K | 1.24% | 26 |
|
|
2021
Q1 | $3.53M | Buy |
46,867
+14,705
| +46% | +$1.07M | 1.21% | 28 |
|
|
2020
Q4 | $2.2M | Sell |
32,162
-428
| -1% | -$27.8K | 0.79% | 36 |
|
|
2020
Q3 | $1.9M | Buy |
32,590
+1,293
| +4% | +$80.5K | 0.78% | 38 |
|
|
2020
Q2 | $2.03M | Sell |
31,297
-463
| -1% | -$29.2K | 0.95% | 38 |
|
|
2020
Q1 | $1.88M | Buy |
31,760
+13,526
| +74% | +$903K | 1.02% | 36 |
|
|
2019
Q4 | $1.35M | Buy |
18,234
+2,984
| +20% | +$210K | 0.61% | 47 |
|
|
2019
Q3 | $962K | Buy |
15,250
+5,811
| +62% | +$344K | 0.45% | 55 |
|
|
2019
Q2 | $514K | Buy |
9,439
+2,783
| +42% | +$150K | 0.25% | 79 |
|
|
2019
Q1 | $359K | Sell |
6,656
-843
| -11% | -$52K | 0.19% | 87 |
|
|
2018
Q4 | $491K | Buy |
+7,499
| New | +$560K | 0.31% | 66 |
|
|
2017
Q3 | – | Sell |
-4,789
| Closed | -$385K | – | 120 |
|
|
2017
Q2 | $385K | Buy |
+4,789
| New | +$378K | 0.25% | 77 |
|
|
2016
Q3 | – | Sell |
-24,771
| Closed | -$2.37M | – | 93 |
|
|
2016
Q2 | $2.37M | Buy |
24,771
+5,851
| +31% | +$583K | 1.94% | 19 |
|
|
2016
Q1 | $1.96M | Buy |
18,920
+681
| +4% | +$66.2K | 1.66% | 20 |
|
|
2015
Q4 | $1.78M | Buy |
18,239
+2,530
| +16% | +$248K | 1.49% | 26 |
|
|
2015
Q3 | $1.52M | Buy |
15,709
+9,308
| +145% | +$979K | 1.31% | 32 |
|
|
2015
Q2 | $671K | Sell |
6,401
-133
| -2% | -$13.6K | 0.53% | 53 |
|
|
2015
Q1 | $674K | Buy |
6,534
+87
| +1% | +$8.8K | 0.54% | 56 |
|
|
2014
Q4 | $621K | Buy |
+6,447
| New | +$568K | 0.53% | 59 |
|
|
2014
Q2 | – | Sell |
-2,849
| Closed | -$213K | – | 86 |
|
|
2014
Q1 | $213K | Sell |
2,849
-420
| -13% | -$29.7K | 0.2% | 78 |
|
|
2013
Q4 | $234K | Buy |
+3,269
| New | +$210K | 0.22% | 71 |
|
Other funds holding CVS
Westover Capital Advisors's CVS Position: Q1 2024 in Review
Westover Capital Advisors sold out of CVS Health (CVS) in Q1 2024, closing a stake of 5,012 shares — an estimated $396K sold.
Westover Capital Advisors first reported a position in CVS in Q4 2013 and held it in 31 quarters. The position peaked at $4.51M in Q4 2021. 2,177 funds tracked by Wall St. Rank hold CVS as of Q1 2024.
- Westover Capital Advisors reported no remaining CVS Health position as of Q1 2024 after selling out during the quarter.
- Westover Capital Advisors sold 5,012 CVS Health shares in Q1 2024, an estimated $396K.
- Westover Capital Advisors first reported a position in CVS Health in Q4 2013 and held it in 31 quarters.
- Westover Capital Advisors's CVS Health position peaked at $4.51M in Q4 2021.
- 2,177 funds tracked by Wall St. Rank held CVS Health as of Q1 2024.
Based on Westover Capital Advisors's 13F filing for Q1 2024, filed 3 May 2024.